Amyloid diseases of the heart: assessment, diagnosis, and referral
In patients with a non-cardiac biopsy showing amyloid deposition, cardiac involvement has been defined-by a consensus opinion from the 10th International Symposium on Amyloidosis 1 -as either a positive heart biopsy and or/increased left ventricular wall thickness (interventricular septal thickness...
Saved in:
Published in | Heart (British Cardiac Society) Vol. 97; no. 1; pp. 75 - 84 |
---|---|
Main Authors | , , |
Format | Journal Article Book Review |
Language | English |
Published |
London
BMJ Publishing Group Ltd and British Cardiovascular Society
01.01.2011
BMJ Publishing Group BMJ Publishing Group LTD |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | In patients with a non-cardiac biopsy showing amyloid deposition, cardiac involvement has been defined-by a consensus opinion from the 10th International Symposium on Amyloidosis 1 -as either a positive heart biopsy and or/increased left ventricular wall thickness (interventricular septal thickness >12 mm) in the absence of hypertension or other potential causes of true left ventricular hypertrophy. 8 w5 In AL amyloid, the plasma cell number, degree of clonality, the quantity of light chain, and the light chain isotype are related to survival.w4 w6 w7 Senile systemic amyloid Wild-type (non-mutant) transthyretin is the precursor protein of senile systemic amyloid (SSA) and is deposited predominantly in the heart in SSA. |
---|---|
Bibliography: | ArticleID:heartjnl190405 href:heartjnl-97-75.pdf istex:FB1546A3A68F5F7180510805C806953DDDB4811F local:heartjnl;97/1/75 ark:/67375/NVC-MHJXF6WV-9 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ISSN: | 1355-6037 1468-201X |
DOI: | 10.1136/hrt.2009.190405 |